Literature DB >> 19023660

TNF alpha production in morphine-treated human neural cells is NF-kappaB-dependent.

Bassel E Sawaya1, Satish L Deshmane, Ruma Mukerjee, Shongshan Fan, Kamel Khalili.   

Abstract

The cytokine tumor necrosis factor alpha (TNFalpha) is a key factor in several inflammatory diseases and its levels increase in response to a variety of internal or external stimuli. The regulation of the TNFalpha promoter is mediated by several transcription factors including the nuclear factor kappa B protein (NF-kappaB). This study examines the role of NF-kappaB in the regulation of TNFalpha production by morphine in microglia. Using reverse transcriptase polymerase chain reaction, we demonstrated the presence of morphine receptors in these cells. We next demonstrated the ability of morphine to promote TNFalpha production and secretion by these cells using a cytokine array assay. Transient transfection experiments led to the identification of the region located between nucleotides -751 and -615 within the TNFalpha promoter as being responsive to morphine treatment. The DNA sequence of this region contains a motif indicative of a potential NF-kappaB binding site. The use of a small interfering RNA directed against p65, a subunit of NF-kappaB, demonstrated that TNFalpha induction by morphine is NF-kappaB-dependent. All of the effects of morphine were reversed by the morphine inhibitor, naloxone. These data provide important insights into the effects of morphine on microglia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023660     DOI: 10.1007/s11481-008-9137-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  45 in total

1.  HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta.

Authors:  Hui Peng; Nathan Erdmann; Nicholas Whitney; Huangyu Dou; Santhi Gorantla; Howard E Gendelman; Anuja Ghorpade; Jialin Zheng
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

2.  CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.

Authors:  Nazira El-Hage; Guanghan Wu; Jayakrishna Ambati; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmunol       Date:  2006-07-10       Impact factor: 3.478

3.  Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

4.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

Authors:  M Kriegler; C Perez; K DeFay; I Albert; S D Lu
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

5.  Cytokine reversal of morphine-induced suppression of the antibody response.

Authors:  J L Bussiere; M W Adler; T J Rogers; T K Eisenstein
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

6.  Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells.

Authors:  Rajesh Aneja; Kelli Odoms; Katherine Dunsmore; Thomas P Shanley; Hector R Wong
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

9.  Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions.

Authors:  Young Jin Lim; Shuqiu Zheng; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

10.  Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation.

Authors:  Rajani S Bhat; Madhu Bhaskaran; Anil Mongia; Naoko Hitosugi; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2004-03-23       Impact factor: 4.962

View more
  15 in total

Review 1.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

3.  Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat.

Authors:  Maria Meringolo; Valentina Brusadin; Maria T De Luca; Christian Montanari; Christian L Montanari; Letizia Antonilli; Paolo Nencini; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2011-10-21       Impact factor: 4.530

Review 4.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

Review 5.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

6.  Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.

Authors:  Rajnish S Dave; Kamel Khalili
Journal:  J Cell Biochem       Date:  2010-07-01       Impact factor: 4.429

7.  Toll-like receptor 4-mediated nuclear factor-κB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats.

Authors:  Liying Bai; Caihong Zhai; Kun Han; Zhisong Li; Junliang Qian; Ying Jing; Wei Zhang; Ji-Tian Xu
Journal:  Neurosci Bull       Date:  2014-12-02       Impact factor: 5.203

Review 8.  Opioids and Cancer Mortality.

Authors:  Jaya Amaram-Davila; Mellar Davis; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2020-02-20

Review 9.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 10.  Glial and neuroinflammatory targets for treating substance use disorders.

Authors:  Ryan K Bachtell; Jermaine D Jones; Keith G Heinzerling; Patrick M Beardsley; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.